Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 017020
Company: ABBOTT
Company: ABBOTT
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
PANWARFIN | WARFARIN SODIUM | 2MG | TABLET;ORAL | Discontinued | None | No | No |
PANWARFIN | WARFARIN SODIUM | 2.5MG | TABLET;ORAL | Discontinued | None | No | No |
PANWARFIN | WARFARIN SODIUM | 5MG | TABLET;ORAL | Discontinued | None | No | No |
PANWARFIN | WARFARIN SODIUM | 7.5MG | TABLET;ORAL | Discontinued | None | No | No |
PANWARFIN | WARFARIN SODIUM | 10MG | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
08/11/1972 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
02/25/1987 | SUPPL-12 | Labeling |
Label is not available on this site. |
||
09/25/1984 | SUPPL-11 | Manufacturing (CMC)-Formulation |
Label is not available on this site. |
||
06/29/1982 | SUPPL-10 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
09/26/1980 | SUPPL-8 | Labeling |
Label is not available on this site. |
||
03/30/1979 | SUPPL-7 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
01/11/1979 | SUPPL-6 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
04/28/1976 | SUPPL-4 | Labeling |
Label is not available on this site. |
||
12/12/1975 | SUPPL-3 | Labeling |
Label is not available on this site. |
||
06/23/1975 | SUPPL-2 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
03/03/1975 | SUPPL-1 | Unspecified |
Label is not available on this site. |